Eletriptan Hydrobromide, CAS number 143322-58-1, is a medication indicated for the acute treatment of migraine with or without aura in adults. Known as Relpax, which is marketed by Pfizer, the patent expiration for Eletriptan Hydrobromide is on December 26, 2016 (Patent Use Code U – 876 – TREATMENT OF MIGRAINE WITH OR WITHOUT AURA). Available in[…]
Migraine Sufferers Find Relief with Eletriptan Hydrobromide
Anti-Migraine, Drug Research & Development API, Patent Expiration 2016 Tags: migrainesPfizerWorld Health Organization Jan 09, 2013
Lamivudine Is Still a Formidable Treatment for HIV and HBV
Anti-Retroviral / Anti-HIV, Antiviral, Patent Expiration 2016 Tags: antiretroviral therapychronic hepatitis BHIV virus Nov 12, 2012
Lamivudine is also known as Epvir. Marketed by GlaxoSmithKline, the patent for Epvir is due to expire on May 18, 2016. Lamivudine is an antiviral medication that prevents human immunodeficiency virus (HIV) or hepatitis B (HBV) virus cells from multiplying in the body. This medication will treat HIV and HBV, but it is not a[…]
Schizophrenia Patients Have an Option with Iloperidone
Antipsychotic, Drug Research & Development API, Patent Expiration 2016 Tags: antipsychoticSchizophrenia Oct 26, 2012
Iloperidone, CAS# 133454-47-4 is an antipsychotic medication. Known as the brand name Fanapt, the patent for this efficacious medication expires for Novartis on November 15, 2016. Iloperidone is available as tablets in dosages of 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg, and is intended primarily for the[…]
Clobetasol Propionate Treats Troubling Skin Condition
Anti-Inflammatory, Drug Research & Development API, Patent Expiration 2016 Tags: Psoriasis Oct 12, 2012
As a prescription medication used to treat adults and children 12 years and older with psoriasis or other certain skin conditions that cause red, flaky, and itchy skin, Clobetasol propionate, CAS number 25122-56-7, is effective and safe. Known as the brand name Olux, which is marketed by Stiefel Laboratories, clobetasol propionate has a patent expiration[…]
Ciprofloxacin Hydrochloride – a Distinguished Antibiotic
Anti-Inflammatory, Antibiotic, Bulk Active Ingredient, Drug Research & Development API, Patent Expiration 2016, Respiratory Tract Agent Tags: antibiotic Oct 11, 2012
Ciprofloxacin Hydrochloride, known as the brand name antibiotic Proquin XR, is an effectual fluoroquinolone. Marketed by Depomed, the patent for Proquin XR is set to expire on September 19, 2016. It is projected to flourish as a generic antibiotic, due in part to its ease of use as a once daily 500 milligram dose. Another[…]
Patients with Plaque Psoriasis Find Relief with Betamethasone Valerate
Anti-Inflammatory, Bulk Active Ingredient, Drug Research & Development API, Patent Expiration 2016 Tags: plaque psoriasis Sep 24, 2012
The National Psoriasis Foundation reports that 7.5 million Americans suffer from psoriasis. This staggering number only highlights the need for effective and safe medications to treat this frustrating, embarrassing and uncomfortable condition. Betamethasone Valerate is known as Luxiq, which is marketed by Stiefel and GlaxoSmithKline. As an aerosol foam treatment for patients with scalp psoriasis,[…]
Children with Growth Issues Benefit from Somatropin
Drug Research & Development API, Hormonal Agent, Patent Expiration 2016 Tags: cystic fibrosis Sep 21, 2012
Somatropin is a human growth hormone, also known in the pharmaceutical and medical community as hGH. The brand, Norditropin, which is marketed by Novo Nordisk, has a patent expiration of December 16, 2015. As an injectable treatment for children who have growth failure, either due to low or no growth hormone, somatropin is safe and[…]
Powerhouse Type 2 Diabetes Medication Exenatide Aids Patients with Weight Loss
Anti-Diabetic, Blood Glucose Regulator, Bulk Active Ingredient, Drug Research & Development API, Patent Expiration 2016, TEVA API Tags: type 2 diabetes mellitus Sep 11, 2012
Exenatide, CAS number 141758-74-9 is an injectable prescription medication that helps to improve blood sugar, or glucose control in adults with type 2 diabetes mellitus. Exenatide, derived from a compound found in the saliva of the Gila monster, a large lizard native to the southwestern US, is a functional analog of Glucagon-Like Peptide-1 (GLP-1), a naturally[…]
Carvedilol Phosphate is a Beta-Blocker to Watch
Bulk Active Ingredient, Cardiovascular Agent, Drug Research & Development API, Patent Expiration 2016 Tags: beta-blockerchronic heart failureheart failurehypertension Sep 04, 2012
Carvedilol Phosphate, CAS number 72956-09-3, is known as the blockbuster medication Coreg CR. GlaxoSmithKline holds the patent for Coreg CR until February 7, 2016. Useful for treating patients with hypertension and mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, carvedilol phosphate is available for research and development from LGM Pharma. In the group of[…]
Gabapentin Used In a Unique Pharmacokinetic Profile
Analgesic, Antiparkinson Agent, Drug Research & Development API, Patent Expiration 2016 Aug 21, 2012
Intended for patients experiencing post herpetic neuralgia, or pain after shingles, gabapentin is unique by design. Known as the brand name Gralise, which is marketed by Depomed and Abbott, this form of gabapentin is specifically made as an oral, once-a-day prescription medication, which offers 24-hour pain control for people with after-shingles pain. Gabapentin, CAS number[…]
- 1
- 2
